UBS Group Trims Celsius (NASDAQ:CELH) Target Price to $64.00

Celsius (NASDAQ:CELH) had its price target dropped by investment analysts at UBS Group from $70.00 to $64.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s target price would suggest a potential upside of 58.69% from the stock’s current price.

A number of other analysts have also recently commented on CELH. Stifel Nicolaus restated a “buy” rating and set a $65.00 target price on shares of Celsius in a report on Tuesday, July 9th. Roth Mkm dropped their price target on shares of Celsius from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Wednesday. Maxim Group cut their price objective on Celsius from $90.00 to $65.00 and set a “buy” rating for the company in a research note on Wednesday. Wedbush cut their price objective on Celsius from $85.00 to $83.00 and set an “outperform” rating for the company in a research note on Wednesday, June 12th. Finally, Truist Financial assumed coverage on Celsius in a research note on Tuesday, June 25th. They issued a “hold” rating and a $60.00 price target for the company. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Celsius has a consensus rating of “Moderate Buy” and an average price target of $68.98.

Celsius Stock Performance

Shares of NASDAQ CELH traded down $0.05 during mid-day trading on Wednesday, hitting $40.33. The stock had a trading volume of 4,687,421 shares, compared to its average volume of 5,172,521. Celsius has a 1 year low of $39.01 and a 1 year high of $99.62. The business has a 50 day moving average price of $58.72 and a two-hundred day moving average price of $69.59. The firm has a market cap of $9.40 billion, a P/E ratio of 44.49, a price-to-earnings-growth ratio of 1.38 and a beta of 1.90.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.05. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The business had revenue of $402.00 million for the quarter, compared to analysts’ expectations of $391.07 million. During the same quarter in the previous year, the business posted $0.17 earnings per share. The firm’s revenue for the quarter was up 23.4% compared to the same quarter last year. Equities research analysts predict that Celsius will post 1.05 EPS for the current fiscal year.

Insider Activity

In other news, Director Hal Kravitz sold 16,500 shares of the firm’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total transaction of $1,489,455.00. Following the transaction, the director now owns 201,282 shares in the company, valued at $18,169,726.14. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Hal Kravitz sold 16,500 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total transaction of $1,489,455.00. Following the sale, the director now owns 201,282 shares of the company’s stock, valued at $18,169,726.14. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder William H. Milmoe sold 40,000 shares of the firm’s stock in a transaction dated Friday, May 17th. The shares were sold at an average price of $92.95, for a total value of $3,718,000.00. Following the sale, the insider now directly owns 226,245 shares in the company, valued at approximately $21,029,472.75. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Celsius by 183.6% in the fourth quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock worth $749,458,000 after acquiring an additional 8,899,873 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Celsius by 212.2% in the fourth quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock worth $185,018,000 after acquiring an additional 2,306,598 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Celsius by 424.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock worth $152,287,000 after purchasing an additional 2,261,046 shares during the last quarter. Eagle Asset Management Inc. increased its position in shares of Celsius by 188.8% in the fourth quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after buying an additional 1,934,400 shares in the last quarter. Finally, Artisan Partners Limited Partnership purchased a new stake in shares of Celsius in the fourth quarter valued at approximately $101,116,000. Institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.